Biotricity Inc Stock News

Biotricity's latest patents focus on a multi-biometric device platform that functions as both a patch and watch, advancing biometric monitoring solutions for remote patient care.

REDWOOD CITY, Calif., Feb. 20, 2025 (GLOBE NEWSWIRE) -- Biotricity Inc.  (OTCQB: BTCY) (“Biotricity” or the “Company”), a top Technology-as-a-Service (TaaS) company that is redefining the healthcare industry with state-of-the-art remote monitoring and diagnostic solutions, today announced its financial results for the third quarter of fiscal 2025 year and (unaudited) ended December 31, 2024.

REDWOOD CITY, Calif., Feb. 17, 2025 (GLOBE NEWSWIRE) -- Biotricity Inc. (OTCQB: BTCY) (“Biotricity” or the “Company”), a Technology-as-a-Service (TaaS) company operating in the remote cardiac monitor sector of consumer healthcare, today provided guidance on its financial results for the third quarter of fiscal 2025 year and (unaudited) ended December 31, 2024.

Purpose Bitcoin Yield ETF offers monthly distributions and long-term capital appreciation through holding Bitcoin and a covered call strategy. The ETF generates a 12.07% yield over a rolling 12-month period. Eligible for TFSAs and RRSPs, the ETF offers potential tax benefits, making it an attractive option for tax-efficient investment growth.

REDWOOD CITY, Calif. and BELFAST, Northern Ireland , Jan. 15, 2025 /PRNewswire/ --  Biotricity Inc. (OTCQB:BTCY), a provider of remote cardiac monitoring solutions, and B-Secur, a leader in biosensing technology, have joined forces to create one of the most advanced, device-neutral platforms for integrated heart monitoring.

Company Receives Capital Needed from its Term Lender and Existing Investors to Reach Profitability without any need for future financing. REDWOOD CITY, Calif.

First Time in the Company's History REDWOOD CITY, Calif. , Dec. 3, 2024 /PRNewswire/ -- Biotricity Inc. (OTCQB: BTCY) ("Biotricity" or the "Company"), a Technology-as-a-Service (TaaS) company operating in the remote cardiac monitor sector of consumer healthcare, today announced achieving positive free cash flow, a measure of financial health and another major milestone towards profitability.

Biotricity, Inc. (OTC:BTCY) Q2 2025 Earnings Conference Call November 15, 2024 4:30 PM ET Company Participants Dr. Waqaas Al-Siddiq - Founder and CEO John Ayanoglou - Chief Financial Officer Conference Call Participants Kevin Dede - H.C. Wainwright Operator Greetings.